- Advising large pharmaceutical company’s defense of inter partes reexamination to avoid intervening rights
- Appealing medical device company’s ex parte reexamination to CAFC, to obtain remand back to USPTO
- Optimizing medical device company’s US post-grant portfolio strategy from among eight possible proceedings, without the benefit of final PTO rules
- Quieting aggressive trademark bully in multiple international jurisdictions
- Cutting short bad faith derived filing of specialty chemical client’s invention by industry giant
- Filing software venture’s core technology to obtain EPO search results before Paris Convention deadline
- Designing and drafting medical device company’s global patent and design portfolio
- Preventing cross border and divided infringement design around of hundreds of Global 500 clients’ patents
- Clearing alternative energy company’s path to funding through exhaustive and decisive invalidity opinions
- Optimizing non-US patent law firm’s FITF, FTI & hybrid application prior art regime filing strategies
- Introducing startup to ideal testing facilities and investors
